
Suchergebnisse
17 results found with an empty search
- Download | Dr. Fooke GmbH
ALLERGY DIAGNOSTICS Download AUTOIMMUNE DIAGNOSTICS Download INFECTION DIAGNOSTICS Download
- Kopie von Download | Dr. Fooke GmbH
ALLERGY DIAGNOSTICS Download AUTOIMMUNE DIAGNOSTICS Download INFECTION DIAGNOSTICS Download Download Allergen list 2019-2020 Download Recombinant allergens 2019-2020 Download Product catalog 2019-2020 Download FLYER currently
- Veranstaltungen | Dr. Fooke GmbH
No events at the moment
- Allergie | Diagnostik | Dr. Fooke-Achterrath Laboratorien GmbH | Neuss
Tests für die in-vitro Allergie und Autoimmun Diagnostik, Allergie- und Autoimmun-Testsysteme, Mikrobiologie, www.fooke-labs.de, Dr. Fooke-Achterraht Laboratorien GmbH, COVID-19, Infektionsdiagnostik, Service, Qualität, Zuverlässigkeit, Erfahrung MORE ABOUT OUR PRODUCTS Nach oben Anker 1 Allergy diagnostics in-vitro allergy diagnostics: Symptoms, triggers & causes. We offer you modern and innovative tests for in-vitro allergy and autoimmune diagnostics. Allergy diagnostics Autoimmune diagnostics Organ-specific, systemic or intermediate diseases. Autoimmune diseases are malfunctions in the immune system in which the body's own structures such as cells and organs are attacked Autoimmune diagnostics Infection diagnostics SARS-CoV-2 / COVID-19 antibody test Test the effectiveness of a COVID-19 vaccination or find out whether you have already had COVID-19. Infection diagnostics Microbiology We are your service provider for microbiological analysis of food, drinking water, cosmetics and therefore your partner for your quality assurance. Accredited according to DIN EN ISO / IEC 17025 microbiology Molecular allergy diagnostics Recombinant or native allergens in type I allergy diagnostics. What are allergen molecules, allergen components? Recognize primary sensitization. Differentiate sensitizations. Identify risk markers Molecular allergy diagnostics ALFA (Allergy Lateral Flow Assay) Test result within 20 minutes 150 freely selectable allergen solutions Rapid test for the semi-quantitative determination of total immunoglobulin E (tIgE) Allergy Lateral Flow Assay Autoimmune ELISA Kits More confidence in autoimmune diagnostics Symptoms and their consequences Organ-specific and systemic autoimmune diseases Autoimmune ELISA Kits ALLERGO-O-LIQ Quantitative determination of specific IgE and total IgE "Sandwich ELISA" in microtiter plates more than 500 complete allergen extracts & allergen mixtures 2 plate and 4 plate machine ALLERGO-O-LIQ Project Sustainability 2022 CONTACT We'd love to hear from you information@fooke-labs.de +49 (0) 2131 2984-0 Send us a message Up
- Projekt Climate Neutral | Dr. Fooke GmbH
Sustainability Project climate neutral 2022 CLIMATE-NEUTRAL - what does that actually mean? The term climate neutrality describes processes in which the atmospheric equilibrium is not changed and in the course of which there is no net emission of greenhouse gases. The basis for the assessment are the emissions of climate-relevant gases, in particular CO2. Processes are therefore described as climate-neutral if no climate-relevant gases escape or if gases that have already been emitted are saved elsewhere. Since the total content of greenhouse gases in the atmosphere alone is decisive for the extent of global warming, compensatory measures elsewhere can also be used to implement computationally climate-neutral processes. Here too, however, comprehensive balancing and control are necessary in order to be able to ensure that emissions in one location actually correspond to savings in the same amount in another. In this context, one speaks of climate neutrality through compensation. Climate protection measures should be able to be implemented cost-effectively by means of climate compensation. The carbon dioxide emissions in one place are offset by greenhouse gas savings elsewhere. CO2 offsets were initially only offered for air travel. In the meantime, however, the idea has been expanded to include a wide variety of products and services. Dr. Margrit Fooke-Achterrath Managing Director (CEO) Dr. Margrit Fooke-Achterrath Managing Director (CEO) Um das Ziel einer klimaneutralen Produktion bis 2022 zu erreichen und im Anschluss halten zu können, haben und werden wir in zukunftsorientierte Systeme investieren. Ein langfristiges und nachhaltiges Denken gilt nicht nur für betriebswirtschaftliche Faktoren, sondern auch für umweltrelevante Themen. Our way 2022 "plus minus zero CO2" Green electricity We have been moving in since 2017 100% green electricity . This electrical energy is obtained exclusively from environmentally friendly, renewable energy sources and is part of a sustainable energy supply. Life cycle Assessment Target: Process optimization for "sustainable" production by 2022 PV-System The sun is the greatest source of energy on earth. It supplies us with light and warmth and is therefore indispensable for life on earth. It is inexhaustible (in contrast to fossil fuels such as coal and oil) and is therefore one of the renewable Energies. Since 2019 we have been operating our own PV system with an output of 90 kwp. In this way we are able to produce a large part of our energy needs ourselves. Our facility is clean and emission free (no CO2, soot or fine dust). Electromobility Electromobility is the key to climate-friendly mobility and innovation worldwide. The operation of electric vehicles generates significantly less CO2, especially in connection with electricity generated from renewable sources. Our energy concept of the future is inconceivable without electromobility. Electric cars are the beginning of a different logic of energy and mobility. The batteries of electric vehicles are ideal for this. “Vehicle-to-Grid” is the magic formula of the future, which will turn cars into energy stores. We have therefore decided to switch to the new drive types in the long term. We don't pretend we have all the answers! But what we have is a plan with the goal of trying to achieve something. There is always more to be done. Together!